Conference call follow-up

13/05/22 -"Orpea held a conference call after the release of its FY21 results and Q1 22 revenue, giving a further insight into its future. "

Executive summary
Conflict of interest

Pages

Language

English

Published on

13/05/22

Download

You may also be interested by these reports :

14/11/25

Sonova Holding

Sonova reported decent H1 results, with sales aligning with the company-compiled consensus. However, normalised EBITA did not meet expectations due ...

13/11/25

Alcon

The Q3 results were somewhat ahead of expectations, and the 2025 guidance was maintained this time, after two downgrades earlier this year. This, ...

07/11/25

Gn Store Nord

GN’s Q3 results fell short of expectations. Sales growth in Hearing and Gaming was nearly counterbalanced by weakness in Enterprise. Profitability ...

06/11/25

DiaSorin

DiaSorin’s Q3 results did not meet expectations, with all segments underperforming except for immunodiagnostics. As a result, management has lowered ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue

Emeis